pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
globenewswire health·2d ago·1 min read
save

Nokia executive Patrik Hammarén reports share purchase of 43,293 shares at €8.44 each

Jul 27, 2026·read at globenewswire health ↗DealNeutral

Nokia Oyj disclosed a leadership transaction filed under market abuse regulation article 19. The filing lists senior executive Patrik Hammarén as the reporting person.

The transaction involved a total of 43,293 shares purchased at a unit price of €8.4420. The purchase was split into two tranches of 1,624 shares and 41,669 shares, both at the same price, resulting in an average price of €8.4420 per share.

Nokia describes itself as a technology leader in AI‑era network solutions, covering fixed, mobile and transport networks. Contact details for communications and investor relations were also provided in the filing.

source

This writeup was produced by pharmadog from original reporting by globenewswire health.

Original headline: “Nokia Oyj - Johtohenkilöiden liiketoimet (Hammarén)”

read at globenewswire health ↗
95 words · retrieved 5h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 21h agoDSV, 1172 - MANAGER'S TRANSACTIONS IN DSV A/S SHARESglobenewswire health
  • 23h agoOKYO Pharma Announces Purchase of Shares by Chief Scientific Officerglobenewswire health
  • 1d agoDanske Bank A/S, ledende medarbejderes transaktionerglobenewswire health
  • 1d agoDanske Bank A/S, transactions by persons discharging managerial responsibilitiesglobenewswire health
  • 1d agoVaisala Oyj: Johtohenkilöiden liiketoimet – Pylvänäinen, Vesaglobenewswire health